AIM
CASC

Alambic Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Alambic Investment Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,750
Closed -$61K – 746
2017
Q1 		$61K Buy
+14,750
New +$61K 0.01% 617